Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5.0Revenue (TTM) $M1.8Net Margin (%)-830.7Altman Z-Score-10.8
Enterprise Value $M7.7EPS (TTM) $-10.2Operating Margin %-927.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-830.7Higher ROA y-yN
Price/Book0.110-y EBITDA Growth Rate %-9.7Quick Ratio1.1Cash flow > EarningsN
Price/Sales0.15-y EBITDA Growth Rate %-46.6Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-57.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-182.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M31.8ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with DCTH

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DCTH is held by these investors:



DCTH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Taglietti MarcoDirector 2015-07-28Buy12,500$8.48-98.11view
STOLL ROGER G PHDDirector 2015-07-27Buy1,250$8.64-98.15view
Philips Laura ADirector 2015-07-23Buy10,166$8-98view
Rueckert William DodgeDirector 2015-07-22Buy1,250$7.68-97.92view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-97.92view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-97.92view
LEUNG GABRIELDirector 2012-06-15Buy29$401.92-99.96view
Koplewicz Harold SDirector 2012-06-01Buy260$381.44-99.96view
Purpura JohnEVP Reg. Affairs/Quality Assur 2012-06-01Buy20$381.44-99.96view
HOBBS EAMONN PPresident and CEO 2012-06-01Buy27$389.12-99.96view

Quarterly/Annual Reports about DCTH:

News about DCTH:

Articles On GuruFocus.com
Five NCAV Companies for Value Investors – August 2015 Aug 04 2015 
Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
Delcath Systems Inc. Reports Operating Results (10-Q) Oct 23 2009 

More From Other Websites
DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Feb 15 2017
Delcath Systems to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Feb 06 2017
DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 30 2017
DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Jan 26 2017
Delcath Systems To Present At The NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor... Jan 23 2017
New Outcomes Data Using Delcath's Melphalan/HDS To Treat Unresectable Metastatic Ocular Melanoma To... Jan 18 2017
Delcath Announces Ongoing Patient Treatment And Data Collection In Intrahepatic Cholangiocarcinoma... Jan 12 2017
DryShips, Merrimack Tumble into Friday’s 52-Week Low Club Jan 06 2017
Delcath Systems to Present at the 9th Annual LD Micro Main Event Nov 30 2016
DELCATH SYSTEMS, INC. Financials Nov 18 2016
Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
Delcath Announces Third Quarter Financial Results Nov 11 2016
Delcath Announces Third Quarter Financial Results Nov 11 2016
DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2016
DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 18 2016
Delcath Issues Letter to Stockholders Oct 18 2016
Delcath Issues Letter to Stockholders Oct 18 2016
Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy Oct 17 2016
Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy Oct 17 2016
Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver... Oct 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)